Forecast: Trachea, Bronchus or Lung Malignant Neoplasms Mortality in Canada

The forecast for mortality due to trachea, bronchus, or lung malignant neoplasms in Canada suggests a gradual decline from 44.4 deaths per hundred thousand persons in 2024 to 40.4 by 2028, based on standardised rates. This trend represents an average annual decrease of approximately 2.3% over the five-year period. The year-on-year variation shows a consistent reduction, reflecting effective healthcare interventions and public health initiatives.

Looking ahead, it is important to monitor:

• The impact of new healthcare policies and cancer treatment advancements.
• Changing smoking behaviors and environmental factors.
• Innovations in early detection and diagnosis technologies.